Dengue Virus Infection
Conditions
Brief summary
The primary objective of the study is to evaluate the effectiveness of additional risk minimization measures material by assessing the knowledge and understanding of healthcare professionals regarding the key safety messages provided in the material. The secondary objective of the study is to evaluate if healthcare professionals know Dengvaxia product information, namely, age indication and contraindications.
Detailed description
The study is a cross-sectional Survey. Study data are collected through a questionnaire.
Interventions
OTHERNo intervention
Questionnaire
Sponsors
Sanofi Pasteur, a Sanofi Company
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
\- Healthcare professionals who are current or past prescribers of Dengvaxia
Exclusion criteria
* Healthcare professionals who have never prescribed Dengvaxia * Healthcare professionals who may have a conflict of interest with the survey (i.e. Healthcare professionals employed by regulatory bodies, pharmaceutical industries) * Healthcare professionales who have participated in testing the questionnaire for comprehensibility, consistency and the appropriateness of medical terms The above information is not intended to contain all considerations relevant to participation in the survey.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Healthcare professionals' knowledge and understanding of key safety messages provided in risk minimization measures materials | Day 0 | Knowledge and understanding of key safety messages are assessed through a questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Healthcare professionals' knowledge of Dengvaxia product information | Day 0 | Knowledge of Dengvaxia product information (age indication and contraindications) is assessed through a questionnaire |
Countries
France
Outcome results
None listed